243 related articles for article (PubMed ID: 19416081)
1. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
[TBL] [Abstract][Full Text] [Related]
2. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
4. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
5. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum.
Albrethsen J; Bøgebo R; Olsen J; Raskov H; Gammeltoft S
Clin Chem Lab Med; 2006; 44(10):1243-52. PubMed ID: 17032137
[TBL] [Abstract][Full Text] [Related]
6. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
7. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.
Pieragostino D; Petrucci F; Del Boccio P; Mantini D; Lugaresi A; Tiberio S; Onofrj M; Gambi D; Sacchetta P; Di Ilio C; Federici G; Urbani A
J Proteomics; 2010 Jan; 73(3):579-92. PubMed ID: 19666151
[TBL] [Abstract][Full Text] [Related]
8. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
9. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
10. Protein detection in dried blood by surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS).
Dammann CE; Meyer M; Dammann O; von Neuhoff N
Biol Neonate; 2006; 89(2):126-32. PubMed ID: 16210847
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
12. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
13. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
14. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
15. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
16. Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.
Lei L; Wang XJ; Zheng ZG; Huang J; Cao WM; Chen ZH; Shao XY; Cai JF; Ye WW; Lu HY
Anat Rec (Hoboken); 2011 Jun; 294(6):941-4. PubMed ID: 21548109
[TBL] [Abstract][Full Text] [Related]
17. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
18. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.
Timms JF; Arslan-Low E; Gentry-Maharaj A; Luo Z; T'Jampens D; Podust VN; Ford J; Fung ET; Gammerman A; Jacobs I; Menon U
Clin Chem; 2007 Apr; 53(4):645-56. PubMed ID: 17303688
[TBL] [Abstract][Full Text] [Related]
19. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
Ndao M
Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]